Long-Term Outcome of Intact Abdominal Aortic Aneurysm After Endovascular or Open Repair

医学 围手术期 危险系数 腹主动脉瘤 腔内修复术 倾向得分匹配 外科 优势比 置信区间 回顾性队列研究 动脉瘤 队列 主动脉瘤 存活率 内科学
作者
Jasmin Epple,Yuliya Svidlova,Thomas Schmitz‐Rixen,Dittmar Böckler,Neelam Lingwal,Reinhart T. Grundmann
出处
期刊:Vascular and Endovascular Surgery [SAGE Publishing]
卷期号:57 (8): 829-837 被引量:3
标识
DOI:10.1177/15385744231178130
摘要

Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable.In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018.In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients.The perioperative mortality was 1.9% for EVAR and 5.9% for OAR (P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR (P = .102). The operation method didn't influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort (P ≤ .001).EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons' experience, and the institutions' ability to handle complications.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
静心龙完成签到,获得积分10
刚刚
完美青旋完成签到,获得积分10
1秒前
sci_zt完成签到 ,获得积分10
2秒前
free完成签到,获得积分10
3秒前
someone发布了新的文献求助10
4秒前
自觉柠檬完成签到 ,获得积分10
6秒前
zoe完成签到,获得积分10
10秒前
白嫖论文完成签到 ,获得积分10
10秒前
zhuao完成签到,获得积分10
12秒前
任十三完成签到 ,获得积分10
12秒前
shouz完成签到,获得积分10
12秒前
13秒前
123完成签到,获得积分10
13秒前
Feiyan完成签到,获得积分10
15秒前
烂漫的煎饼完成签到 ,获得积分10
16秒前
dennis完成签到,获得积分20
16秒前
巨型肥猫完成签到 ,获得积分10
18秒前
qaplay完成签到 ,获得积分0
18秒前
烤番薯发布了新的文献求助10
18秒前
tuzi完成签到,获得积分10
18秒前
俊秀的思山完成签到,获得积分10
19秒前
wzy小号完成签到 ,获得积分10
20秒前
xiaoK完成签到 ,获得积分10
21秒前
坚定蘑菇完成签到 ,获得积分10
25秒前
欢喜的迎丝完成签到,获得积分10
25秒前
柔弱熊猫完成签到 ,获得积分10
27秒前
柏笙笑完成签到 ,获得积分10
31秒前
Hi完成签到,获得积分10
32秒前
努力上进的小张完成签到,获得积分10
36秒前
椿iii完成签到 ,获得积分10
36秒前
暮商完成签到 ,获得积分10
37秒前
彼方完成签到,获得积分10
38秒前
Vincent完成签到 ,获得积分10
41秒前
吕程校完成签到 ,获得积分10
42秒前
zyx完成签到,获得积分10
44秒前
45秒前
ff999完成签到,获得积分0
45秒前
科研助理795应助ly浩采纳,获得10
46秒前
陈光华发布了新的文献求助10
46秒前
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7324082
求助须知:如何正确求助?哪些是违规求助? 8939526
关于积分的说明 18952645
捐赠科研通 6980909
什么是DOI,文献DOI怎么找? 3215319
关于科研通互助平台的介绍 2382740
邀请新用户注册赠送积分活动 2194620